(Adds details and background throughout) Nov 16 (Reuters) – Eli Lilly has agreed to acquire privately held biotech Calytrix Bio for up to $1.5 billion in cash, as it looks to expand the development of
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
OTTAWA, Nov 16 (Reuters) - Bank of Canada Governor Tiff Macklem on Monday announced he…
Nov 16 (Reuters) - A petition calling for Jensen Huang to be reinstated as Nvidia…
LONDON, Nov 16 (Reuters) - British actor Robert Pattinson will be the next James Bond,…
By Lisa Richwine LOS ANGELES, Nov 16 (Reuters) - British singer Raye, the artist behind…
ROME, Nov 16 (Reuters) - Italian construction group Webuild said on Monday it had won…
By Saeed Azhar NEW YORK, Nov 16 (Reuters) - Nvidia's $500 billion AI financing platform…